Biotech will expand production of its growth factors for cultivated meat.
Icelandic biotech firm ORF Genetics has raised €5 million (US$5.9 million) in new funding to scale up production of its growth factors via molecular farming.
“We are at a pivotal moment,” CEO Berglind Rán Ólafsdóttir said in a statement. “This funding ensures that ORF can meet the imminent surge in commercial opportunities and supports the company’s next…
Join for free* to continue reading.
You’ll get access to all Alt-Meat has to offer including full access to our web content devoted to the meat alternatives market.
Already a member? Click here to login>>.
*Free for qualified recipients